Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Dengue
 More »

  • High-Tech Academic Centers Look to Milk Their Cash Cows
    ... Our intention is to sell those quickly into the commercial market, and use the proceeds to augment grants to address diseases of other flaviviruses, such as Dengue fever, West Nile ...
    7-1-2013
  • Booster Shot: Takeda Buys Inviragen
    its advanced vaccine candidate against dengue, a serious mosquito-borne illness that ... The company's lead product is DENVax, a dengue fever vaccine that uses a weakened DEN-2 ...
    5-8-2013
  • GEN | Biolinks
    ... Institute Delaware Economic Development Office Delaware State University Dendreon Dengue Vaccine Initiative Deutsche Industrievereinigung Biotechnologie (DIB) Diffusion ...
  • VaxInnate Wins $2.2M NIAID Grant for Dengue Vaccine
    of a recombinant vaccine for the prevention of dengue. The grant will fund development of a recombinant tetravalent dengue vaccine using VaxInnate's technology, which involves ...
    4-4-2013
  • Astellas Takes On Dengue with a Little Help from Its Friends
    new drugs for the treatment of neglected tropical diseases (NTDs) caused by dengue virus. ... multiple compounds with possible anti-dengue virus activities, and NEKKEN will ...
    3-21-2013
  • Steric Exclusion Chromatography
    ... Similar results have since been achieved with several other bacteriophage species as well as influenza and Dengue virus. These results suggest that the technique will prove to be a ...
    3-15-2013
  • Building a Self-Destructive Mosquito
    Genetically modified mosquitos could be a way to curb the spread of dengue fever in Florida. In 2010, a dengue outbreak was reported in the Florida Keys, in Florida's Monroe County ...
    1-7-2013
  • Nucleic Acid Sample-Prep Tools Break New Ground
    ... flavi-, and bunya-family viruses, dengue, and malaria. "So you can drop the mosquitoes in there and DNA will be taken out, cleaned, amplified, and taken to the sensor, and read. ...
    10-1-2012
  • SBIR Grant for Multifaceted Malaria Vaccine
    expression, process development, and vaccine manufacturing to develop vaccines against P. falciparum and P. vivax malaria, SARS, dengue fever, anthrax, tularemia, and plague. ...
    9-26-2012
  • GenVec Slashes Workforce by 30%
    infectious diseases including respiratory syncytial virus, herpes simplex virus, dengue fever, influenza, malaria, and HIV. At the start of 2010 GenVec and Novartis signed a ...
    9-25-2012
  • Firms Partner on Dual-Vaccine Malaria Program
    The firm is in addition leveraging its expertise to develop vaccines for SARS, dengue fever, tularemia, P. falciparum malaria and P. vivax malaria. Adura is exploiting its Listeria ...
    9-19-2012
  • Sanofi Dengue Vaccine Disappoints on Efficacy
    A Sanofi vaccine for dengue fever produced disappointing results in a Phase IIb clinical ... However, efficacy for the first, third, and fourth dengue fever variations were in a range ...
    9-12-2012
  • Brazil Clears Quest's Simplexa Dengue Assay on 3M Integrated...
    The Brazilian authorities have cleared Quest Diagnostics' Simplexa(tm) Dengue molecular ... is the first commercial real-time PCR Dengue test to be approved for use by Brazil's ...
    12-7-2011
  • PCR-Based Diagnostics Put to the Test
    But in cases involving more heterogeneous viruses like the flaviviruses, dengue, or yellow fever, "we are talking about many, many thousands of sequences, and you have new sequence ...
    10-15-2011
  • United Therapeutics Wins NIAID Contract Worth $45M to Develop...
    drug for diseases such as dengue and flu, based on its glycobiology antiviral platform. ... clinical trials of the candidate against dengue, and also preclinical studies that will ...
    10-11-2011
  • More »

    Journal Articles

  • Density-Dependent Competitive Suppression of Sylvatic Dengue...
    Kim M. Pepin, Kathryn A. Hanley
    Vector-Borne and Zoonotic Diseases
    Density-Dependent Competitive Suppression of Sylvatic Dengue Virus by Endemic Dengue Virus in Cultured Mosquito Cells Vector-Borne and Zoonotic Diseases
  • Antibody to Dengue 1 Detected More Than 60 Years after Infection
    Allison Imrie, Janet Meeks, Alexandra Gurary, Munkhzul Sukhbaatar, Thang Thua Truong, C. Bruce Cropp, Paul Effler
    Viral Immunology
    Antibody to Dengue 1 Detected More Than 60 Years after Infection Viral Immunology
  • Evaluation of the Dengue NS1 Ag Strip ® for Detection of Dengue...
    Cheong-Huat Tan, Pei-Sze Jeslyn Wong, Mei-Zhi Irene Li, Indra Vythilingam, Lee-Ching Ng
    Vector-Borne and Zoonotic Diseases
    Evaluation of the Dengue NS1 Ag Strip ® for Detection of Dengue Virus Antigen in Aedes aegypti (Diptera: Culicidae) Vector-Borne and Zoonotic Diseases Abstract Dengue fever is ...
  • Mosquito Protein Kinase G Phosphorylates Flavivirus NS5 and Alters...
    Julie A. Keating, Dipankar Bhattacharya, Samuel S.C. Rund, Spencer Hoover, Ranjit Dasgupta, Samuel J. Lee, Giles E. Duffield, Rob Striker
    Vector-Borne and Zoonotic Diseases
    PKG from Aedes mosquitoes is able to phosphorylate dengue non-structural protein 5 (NS5) ... This increased PKG activity could be the mechanism by which dengue virus increases flight ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Top Paid Women in Biopharma

Do you think the women on our list of the 20 top paid women executives in biopharma are underpaid?

Suggest a Poll